- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Buy the Dip
Global Pharmaceuticals & Biotech Buy the Dip
Results
17
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
17 companies
Summit Therapeutics
Market Cap: US$14.5b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$19.73
7D
-24.7%
1Y
142.7%
Corcept Therapeutics
Market Cap: US$7.4b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$69.01
7D
-11.1%
1Y
100.1%
Centessa Pharmaceuticals
Market Cap: US$1.7b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
CNTA
US$11.86
7D
-9.3%
1Y
33.0%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥10.2b
Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.
300119
CN¥21.04
7D
-14.4%
1Y
45.5%
ARS Pharmaceuticals
Market Cap: US$1.4b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$13.44
7D
-13.2%
1Y
52.4%
Alphamab Oncology
Market Cap: HK$7.7b
A clinical stage biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology biologics.
9966
HK$7.97
7D
-10.8%
1Y
179.6%
HBM Holdings
Market Cap: HK$6.3b
A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel antibody therapeutics in immunology and oncology disease areas.
2142
HK$7.96
7D
-10.9%
1Y
476.8%
Xeris Biopharma Holdings
Market Cap: US$709.5m
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$4.46
7D
-11.5%
1Y
89.0%
Eton Pharmaceuticals
Market Cap: US$454.6m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$17.25
7D
-8.8%
1Y
373.9%
Faron Pharmaceuticals Oy
Market Cap: UK£279.5m
Operates as a clinical stage drug discovery and development company.
FARN
UK£2.15
7D
-12.2%
1Y
124.0%
Verastem
Market Cap: US$339.0m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$6.18
7D
-20.5%
1Y
69.8%
Green Lifescience
Market Cap: ₩64.5b
Engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally.
A114450
₩3,305.00
7D
-14.4%
1Y
60.8%
Relief Therapeutics Holding
Market Cap: CHF 27.8m
A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally.
RLF
CHF 2.21
7D
-15.0%
1Y
76.8%
PeterLabs Holdings Berhad
Market Cap: RM 99.1m
An investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally.
PLABS
RM 0.36
7D
-12.2%
1Y
80.0%
Biogened
Market Cap: zł65.8m
Develops, produces, and distributes pharmaceutical products in Poland.
BGD
zł26.80
7D
-12.4%
1Y
30.1%
Genetic Analysis
Market Cap: NOK 46.9m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
GEAN
NOK 0.95
7D
-24.0%
1Y
35.7%
Stayble Therapeutics
Market Cap: SEK 29.2m
Develops injectable treatment for chronic pain triggered by disc degeneration.
STABL
SEK 0.45
7D
-12.3%
1Y
60.8%